Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Lithium carbonate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lithium carbonate and what is the scope of lithium carbonate patent protection?

Lithium carbonate
is the generic ingredient in seven branded drugs marketed by Hetero Labs Ltd Iii, Watson Labs, West-ward Pharms Int, Hikma Intl Pharms, Glenmark Generics, Mylan Pharms Inc, Able, Ani Pharms Inc, Sun Pharm Inds Inc, Heritage Pharma, Bayer Pharms, Pfizer, Usl Pharma, Glenmark Pharms Inc, Alembic Pharms Ltd, Jds Pharms, Alembic Ltd, Noven Therap, Barr, Unique Pharm Labs, Solvay, and Apotex Inc, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for lithium carbonate. Thirty-six suppliers are listed for this compound.

Summary for Generic Name: lithium carbonate

Drug Master File Entries: see list15
Suppliers / Packagers: see list36
Bulk Api Vendors: see list55
Clinical Trials: see list155
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lithium carbonate at DailyMed

Pharmacology for Ingredient: lithium carbonate

Drug ClassMood Stabilizer
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
lithium carbonate
CAPSULE;ORAL076823-001Jun 29, 2004DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
lithium carbonate
TABLET;ORAL091027-001Jun 24, 2010ABRXNoNo► Subscribe► Subscribe
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL076366-001Aug 21, 2003DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
lithium carbonate
CAPSULE;ORAL017812-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
West-ward Pharms Int
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL076691-001Jan 5, 2004ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus